Dexcel Pharma
↗Or Akiva, Israel
Dexcel Pharma is the largest private pharmaceutical company in Israel and a significant global player in the branded and generic drug markets. Founded in 1968, the company specializes in the development, manufacturing, and commercialization of high-quality pharmaceuticals across a wide range of therapeutic areas. It is particularly known for its expertise in complex drug delivery systems and value-added generics.
The company operates a vertically integrated model with state-of-the-art R&D centers in Jerusalem and manufacturing facilities in Or Akiva and Yokneam. Dexcel has expanded its international presence significantly, most notably through the acquisition of US-based Edenbridge Pharmaceuticals in 2022, which now operates as Dexcel Pharma USA. The company markets over 85 products in more than 30 countries.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:
Industry:Pharmaceuticals
Sub-Industry:Specialty Generics & Hybrid Medicines
SIZE & FINANCIALS
Employees:1001-5000
Revenue:$100M-$500M
Founded:1968
Ownership:private
Status:operating
FUNDING
Stage:Late Stage / Private
Total Raised:Self-funded / Private
Investors:Oren Family (Owners)
PIPELINE
Stage:Commercial
Lead Drug Stage:Approved/Commercial
Modalities:Small molecule, Complex drug delivery, Modified release, Topical/Oral films
Active Trials:6
Trial Phases:Phase 1: 2 | Phase 2: 1 | Phase 3: 3
FDA Approvals:50
EMA Approvals:30
CORPORATE STRUCTURE
Subsidiaries:Dexcel Pharma USA (formerly Edenbridge), Dexcel Pharma GmbH (Germany), Dexcel Pharma Ltd (UK), Clexio Biosciences (Spin-off), Dexoligo Therapeutics
Key Partnerships:Roivant Sciences (Early investor), Pfizer (Distribution), Sandoz (Partnership in specific generic markets)
COMPETITION
Position:Leader
Competitors:Teva Pharmaceuticals, Sandoz, Viatris, Hikma Pharmaceuticals
LEADERSHIP
Key Executives:
Dan Oren - Founder & Executive Chairman
Ilan Oren - Co-Chief Executive Officer
Douglas Boothe - CEO, Dexcel Pharma USA
Scientific Founders:Dan Oren
Board Members:Dan Oren, Ilan Oren, Uri Oren
LINKS
⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Dexcel Pharma and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Dexcel Pharma. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.